COSMO PHARMACEUTICALS N.V. Voting results from the Extraordinary General Meeting of Cosmo Pharmaceuticals N.V., 5 July 2024
# | Agenda item | In Favour | Against | Abstain | |||
Votes | % | Votes | % | Votes | % | ||
3 | Proposal to adopt the annual accounts of financial year 2023 ("FY 2023"). | 7,173,931 | 100.00% | - | 0.00% | - | 0.00% |
4 | Appropriation of the result of FY 2023. | 7,173,931 | 100.00% | - | 0.00% | - | 0.00% |
5 | Proposal to adopt the proposed resolution of the Board of Directors to declare a distribution out of Cosmo's freely | 7,173,931 | 100.00% | - | 0.00% | - | 0.00% |
distributable reserves. | |||||||
6 | Proposal to adopt the Company's remuneration policy. | 6,957,583 | 96.98% | 216,348 | 3.02% | - | 0.00% |
7 | Proposal to grant ordinary shares and/or the right to subscribe for ordinary shares to the members of the Board of | 6,957,583 | 96.98% | 216,348 | 3.02% | - | 0.00% |
Directors. | |||||||
8 | Proposal to grant discharge to the (former) members of the Board of Directors. | 7,173,931 | 100.00% | - | 0.00% | - | 0.00% |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Cosmo Pharmaceuticals NV published this content on 05 July 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 July 2024 14:18:05 UTC.
